High-resolution mapping of the human T-cell leukemia virus type 1 Rex-binding element by in vitro selection.
AUTOR(ES)
Baskerville, S
RESUMO
Interactions between the Rex protein of HTLV-1 and the genomic Rex-binding element (XBE) mediate the cytoplasmic transport of viral mRNAs. However, it is uncertain which RNA sequences and structures contribute to Rex recognition. A portion of the viral genome that spanned the XBE was partially randomized, and functional Rex-binding variants were selected. Alignment of selected Rex-binding sequences revealed positions that were functionally conserved between different molecules. A model is presented in which a subset of the selected residues are in direct contact with Rex. Positions that covaried with one another were also found. These covariations support a secondary-structural model in which a central paired stem is symmetrically flanked by two bulge loops. On the basis of this model, site-directed mutations of the XBE were constructed and each half molecule was found to bind independently to Rex. The functional residues and secondary structures in the XBE half molecules bear a remarkable resemblance to the transactivation response region element of HIV-1. Since the transactivation response region element is known to interact specifically with arginine residues in the Tat protein, these results suggest that the XBE binds to the arginine-rich RNA-binding domain of Rex in a similar manner. This model is supported by the selection data.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=189694Documentos Relacionados
- In vitro binding of human T-cell leukemia virus rex proteins to the rex-response element of viral transcripts.
- Anti-Rex Aptamers as Mimics of the Rex-Binding Element
- Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein.
- Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element.
- The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation.